Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STREAMLINE: Antiplatelet Management Following Acute Coronary Syndrome
NCT07507500Phase 4Recruiting
- Sponsor
- Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz
- Start
- Sep 2026
- Primary completion
- Jul 2029
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 4 trial of prasugrel, ticagrelor in myocardial infarction (MI), sponsored by Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz. Started Sep 2026; status: recruiting.
02
Drugs
prasugrelticagrelor
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on NCT07507500.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07507500.